What are the management options for epistaxis (nosebleed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Epistaxis (Nosebleed)

The first-line treatment for epistaxis is firm sustained compression to the lower third of the nose for 10-15 minutes, which should be attempted before proceeding to more invasive interventions. 1

Initial Management

  1. First-line measures:

    • Apply firm pressure to the lower third of the nose for 10-15 minutes
    • Consider vasoconstrictor spray (e.g., oxymetazoline/Afrin) with success rates of 65-75% 1
    • Apply ice packs to help constrict blood vessels
    • Topical tranexamic acid is particularly effective for patients on antiplatelet therapy 1, 2

    Recent research shows topical tranexamic acid reduces bleeding time and has fewer rebleeds compared to anterior nasal packing 2

  2. If bleeding persists - Cauterization:

    • Preferred over nasal packing when a specific bleeding site can be identified
    • Electrocautery (especially bipolar) is more effective than chemical cautery with fewer recurrences (14.5% vs. 35.1%) 1, 3
    • Should be performed under local anesthesia
    • Caution: Avoid excessive or extensive cautery to prevent septal damage

Nasal Packing Options

If bleeding continues despite initial measures:

  1. Non-absorbable materials:

    • Petroleum jelly gauze
    • PVA nasal tampons (Merocel)
    • Foley catheter
    • Balloon systems (Rapid-Rhino)
  2. Absorbable materials:

    • Nasal tampon (Nasopore)
  3. Newer hemostatic materials (more effective with fewer complications):

    • Hemostatic gauzes (Surgicel)
    • Thrombin matrix (Floseal)
    • Gelatin sponge (Spongostan)
    • Fibrin glue

Note: Nasal packing carries risks including infection, decreased blood flow to nasal areas, septal perforations, scar bands, pressure sores, and worsening of obstructive sleep apnea 1

Management of Persistent/Severe Bleeding

For refractory cases:

  1. Endoscopic arterial ligation:

    • Primarily targeting the sphenopalatine artery (SPA)
    • Success rate of 97% compared to 62% with conventional nasal packing 1, 3
  2. Embolization:

    • Reserved for intractable cases
    • Success rate of approximately 80%
    • Higher risk of serious complications including stroke (0.9-1.6%) 1

Post-Treatment Care

  • Nasal moisturization with saline gel or spray 1-3 times daily
  • Humidification in dry environments
  • Avoid digital trauma (nose picking) and vigorous nose blowing 1

Special Considerations

Antiplatelet/Anticoagulant Therapy

  • For patients on dual antiplatelet therapy with persistent bleeding, consider temporary discontinuation of one agent (preferably clopidogrel) in consultation with the prescribing physician 1
  • Resume antiplatelet therapy as soon as bleeding is controlled

Anterior vs. Posterior Epistaxis

  • Anterior epistaxis (most common): Usually more easily managed with compression, cautery, or anterior packing
  • Posterior epistaxis (more severe): May require posterior packing, hospitalization, and specialized interventions 1

When to Refer/Emergency Care

Refer to otolaryngology or emergency department for:

  • Posterior epistaxis
  • Bleeding not controlled with anterior packing
  • Recurrent epistaxis despite treatment
  • Suspected underlying pathology requiring endoscopic evaluation 1

Warning Signs Requiring Immediate Attention

  • Return of blood from nose or mouth
  • Fever over 101°F
  • Increasing pain
  • Vision changes
  • Shortness of breath
  • Loss of color around the skin of the nose
  • Facial swelling
  • Diffuse skin rash 1

Diagnostic Evaluation for Recurrent Epistaxis

  • Nasal endoscopy is the best imaging modality for chronic recurrent epistaxis (identifies bleeding site in 87-93% of cases) 1
  • Evaluate for contributing conditions:
    • Hypertension
    • Atherosclerosis
    • Coagulation disorders
    • Chronic kidney or liver disease 1

References

Guideline

Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparative Study of Topical Application of Injection Tranexamic Acid and Anterior Nasal Packing in the Management of Epistaxis.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2024

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.